Hyphens Pharma International Ltd
SGX:1J5
Operating Margin
Hyphens Pharma International Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
SG |
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
88m SGD |
8%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
717.8B USD |
40%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
3%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
364B USD |
26%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.9T DKK |
48%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
207.5B CHF |
33%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
179.4B CHF |
33%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
159.8B GBP |
24%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
191.4B USD |
34%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
11%
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
129.8B USD |
27%
|
Hyphens Pharma International Ltd
Glance View
Hyphens Pharma International Ltd. is an investment holding company, which engages in the provision of specialty pharmaceutical and consumer healthcare products. The firm's principal activities are those of an investment holding company and provision of management services. The firm's segments include specialty pharma principals, proprietary brands, and medical hypermart and digital. The specialty pharma principals segment is engaged in the business of marketing and selling a range of specialty pharmaceutical products with exclusivity in the relevant ASEAN countries. The proprietary brands segment is engaged in the business of developing, marketing and selling its own proprietary range of dermatological products and health supplement products. The medical hypermart and digital segment is a wholesaler of pharmaceuticals and medical supplies in Singapore, which the Company and its subsidiaries position itself as a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Hyphens Pharma International Ltd's most recent financial statements, the company has Operating Margin of 7.7%.